1 year return (CAGR)
-44.49%
Ultragenyx Exchange (NASDAQ, USD)
RARE
14.50
+0.96 (+6.59%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-25.45%
5 year return (CAGR)
-30.33%
10 year return (CAGR)
-14.10%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.54B
Price/Sales
2.15
Ent value
2.96B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
23.46
EPS growth
13.72%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 14.78 |
| Daily high | 16.12 |
| Daily low | 14.47 |
| Daily Volume | 8.12M |
| All-time high | 177.39 |
| 1y analyst estimate | 55.26 |
| Beta | 0.31 |
| EPS (TTM) | -5.75 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 30 Apr 2026 |
Downside potential
Loading...
Downside potential data
| RARE | S&P500 | |
| Current price drop from All-time high | -91.83% | -0.84% |
| Highest price drop | -92.74% | -56.47% |
| Date of highest drop | 16 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -55.44% | -10.68% |
| Avg time to new high | 71 days | 12 days |
| Max time to new high | 1442 days | 1805 days |
News
